Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile?

By Lashen H   Ledger W   Lopez-Bernal A   Barlow D  

Human Reproduction, Vol. 14, Iss. 4, 1999-04 ,pp. : 964-969

Oxford University Press

Access to resources Recommend Favorite

Immunology: Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a woman with a history of allergic reaction to human menopausal gonadotrophin

By Albano C.  

Human Reproduction, Vol. 11, Iss. 8, 1996-08 ,pp. : 1632-1634

Oxford University Press

Access to resources Recommend Favorite

Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.

By Valbuena D   Pellicer A   Guanes P P   Remohí J   Simón C  

Human Reproduction, Vol. 12, Iss. 10, 1997-10 ,pp. : 2118-2122

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles

By Albano C.  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1426-1430

Oxford University Press

Access to resources Recommend Favorite

Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome

By Elgendy M   Afnan M  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2382-2385

Oxford University Press

Access to resources Recommend Favorite